Advances in Artificial Intelligence for Cardiovascular Care—Part 2: Latest Developments & Deployment in Clinical Care

作者：Sneha S. Jain, Pierre Elias, T. Poterucha, Michael Randazzo, F. López Jiménez, R. Khera, M. Perez, David Ouyang, J. Pirruccello, Michael Salerno, A. Einstein, Robert Avram, Geoffrey H. Tison, Girish N. Nadkarni, V. Natarajan, Emma Pierson, A. Beecy, D. Kumaraiah, Christopher M. Haggerty, Jennifer N. Avari Silva, Thomas M. Maddox · 发表于：Journal of the American College of Cardiology · 年份：2024 · DOI：10.1016/j.jacc.2024.03.401 · 被引用次数：63 · 研究领域：Medicine

Recent Artificial Intelligence (AI) advancements in cardiovascular care offer potential enhancements in effective diagnosis, treatment, and outcomes. Over 600 Food and Drug Administration (FDA)-approved clinical AI algorithms now exist, with 10% focusing on cardiovascular applications, highlighting the growing opportunities for AI to augment care. This review discusses the latest advancements in the field of AI, with a particular focus on the utilization of multimodal inputs and the field of generative AI. Further discussions in this review involve an approach to understanding the larger context in which AI-augmented care may exist, and include a discussion of the need for rigorous evaluation, appropriate infrastructure for deployment, ethics and equity assessments, regulatory oversight, and viable business cases for deployment. Embracing this rapidly evolving technology while setting an appropriately high evaluation benchmark with careful and patient-centered implementation will be crucial for cardiology to leverage AI to enhance patient care and the provider experience.